SCHEMBL6980500

SCHEMBL6980500

Cn1cc(-c2c(C#N)n(C(=O)OC(C)(C)C)c(=O)n2-c2cn(CCCN3C(=O)c4ccccc4C3=O)c3ccccc23)c2ccccc21

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CCNT1 O60563 3/20 0.41
CDK9 P50750 3/20 0.41
CCNA2 P20248 1/20 0.37
CDK2 P24941 1/20 0.37
PRKCA P17252 2/20 0.35
PRKCG P05129 1/20 0.35
PRKCB P05771 1/20 0.35
PRKCH P24723 1/20 0.35
PRKCE Q02156 1/20 0.35
PRKCD Q05655 1/20 0.35
CAMK2D Q13557 3/20 0.34
PIM1 P11309 2/20 0.34
GSK3B P49841 1/20 0.33
PRKACA P17612 1/20 0.33
PRKACG P22612 1/20 0.33
PRKACB P22694 1/20 0.33
IDH1 O75874 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7014052 0.80 CCNT1 (0.41) CCNT1CDK9CCNA2CDK2PRKCA
SCHEMBL6983870 0.79 L3MBTL1 (0.36) CCNT1CDK9PRKCAPRKCGPRKCB
SCHEMBL6982735 0.79 CCNT1 (0.41) CCNT1CDK9CDK2PRKCAPRKCG
SCHEMBL6981336 0.76 CCNT1 (0.42) CCNT1CDK9CCNA2CDK2CAMK2D
SCHEMBL6981135 0.70 ALDH1A1 (0.40) CCNT1CDK9CCNA2CDK2CAMK2D
SCHEMBL6985899 0.68 MAPT (0.40) CCNT1CDK9CCNA2CDK2
SCHEMBL6979460 0.66 CAMK2D (0.42) CCNT1CDK9CCNA2CDK2CAMK2D
SCHEMBL6973734 0.66 CAMK2D (0.56) CCNT1CDK9CCNA2CDK2PRKCA
SCHEMBL6978208 0.65 CNR1 (0.40) CCNT1CDK9CCNA2CDK2
SCHEMBL6981421 0.65 ALDH1A1 (0.42) CAMK2DPIM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1095039-B1 NEW PHARMACEUTICALLY ACTIVE COMPOUNDS ASTRAZENECA AB (SE) 2003-08-27 EP disclosed
US-6346625-B1 ENZYME INHIBITORS FOR PROTEIN KINASES ASTRAZENECA AB (SE) 2002-02-12 US disclosed
EP-1095039-A2 NEW PHARMACEUTICALLY ACTIVE COMPOUNDS AstraZeneca AB (SE) 2001-05-02 EP disclosed
WO-2000002877-A2 NEW PHARMACEUTICALLY ACTIVE COMPOUNDS ASTRAZENECA AB (SE) 2000-01-20 WO disclosed